Your browser doesn't support javascript.
loading
Trends in clinical trials for olfactory dysfunction in the COVID-19 era.
Wang, Vickie J; Abdou, Hisham; Sheth, Amar H; Manes, R Peter; Rimmer, Ryan.
Afiliação
  • Wang VJ; Yale School of Medicine, New Haven, Connecticut, USA.
  • Abdou H; Yale School of Medicine, New Haven, Connecticut, USA.
  • Sheth AH; Yale School of Medicine, New Haven, Connecticut, USA.
  • Manes RP; Department of Surgery (Otolaryngology), Yale School of Medicine, New Haven, Connecticut, USA.
  • Rimmer R; Department of Surgery (Otolaryngology), Yale School of Medicine, New Haven, Connecticut, USA.
Int Forum Allergy Rhinol ; 13(10): 1958-1961, 2023 10.
Article em En | MEDLINE | ID: mdl-36851905
ABSTRACT
KEY POINTS Nearly half of all olfactory dysfunction (OD) clinical trials since 2010 are COVID-19-related. COVID-19-related OD trials are published significantly faster than COVID-19-unrelated trials. High-quality clinical trials and publications are crucial to discovering effective treatments.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Transtornos do Olfato Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Transtornos do Olfato Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article